PRTN3 and rheumatoid arthritis: Despite such high individual odds only a relative minority had relevant increased lifetime risks: using the same HLA-SNP model 49 (4.61%) ACPA-positive cases and 1 (0.07%) control had ORs for seropositive RA>20 (lifetime risks >48% if female and >22% if male) in WTCCC.